# Bioverse reviews (2026): GLP-1 telehealth sellers | This GLP The struck-through figures imply a fifty-five percent cut on one line and eleven on the other, with nothing explaining either. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/bioverse Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Two anchors, two stories # Bioverse review The struck-through figures imply a fifty-five percent cut on one line and eleven on the other, with nothing explaining either. ## The verdict Bioverse publishes $129 a month for semaglutide against a struck $289, and $399 for tirzepatide against a struck $449. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection From From $129/mo Prescription Required Compounded Yes — not FDA-approved Bioverse sells both molecules by weekly injection. Each carries a price and an anchor above it, and the gap between them differs sharply by line. 1. ## Who writes the prescription, and what do they see? A prescription precedes dispensing. Nothing describes who writes it or how often a case is reviewed. An anchor is only useful if something explains it. Here one line implies a saving five times the size of the other, and neither anchor is sourced. 2. ## What happens when the dose goes up? Nothing published says what either figure does at a higher dose. No milligram appears beside either. 3. ## What the price includes Six months is $774 on semaglutide and $2,394 on tirzepatide. That is a gap of $1,620 between molecules, which is far wider than most sellers here maintain. 4. ## What it claims, and what it cites Both lines are compounded. A pharmacy prepares them, and the FDA does not review a compounded preparation before dispensing. ## Where it holds up, and where it does not - Strength: Semaglutide is priced low - Strength: Both anchors are shown, not hidden - Strength: Both molecules carry a figure - Limitation: The two anchors imply unequal discounts - Limitation: Neither anchor is explained - Limitation: Tirzepatide costs three times semaglutide - Limitation: Nothing lists the states served ## What the evidence says about this kind of treatment The assessment above is about Bioverse. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader who wants semaglutide cheaply and ignores the struck figure beside it. Wrong for A reader treating either anchor as a price anyone has been charged. ## The evidence behind what Bioverse prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How Bioverse compares | Seller | Who it suits | Go | | --- | --- | --- | | Bionomy Health | Readers who want to be able to stop by doing nothing | | | Society of You | Readers willing to hand over contact details before seeing the monthly rate | | | Believe Health | Readers who want a low flat rate and know what this storefront actually is | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [Onyx Weight Loss](https://thisglp.com/reviews/onyx-weight-loss) [Open Water Rx](https://thisglp.com/reviews/open-water-rx) [Optimized Health](https://thisglp.com/reviews/optimized-health) [Options Medical Weight Loss](https://thisglp.com/reviews/options-medical-weight-loss) [OrderlyMeds](https://thisglp.com/reviews/orderlymeds) [Oria Meds](https://thisglp.com/reviews/oria-meds) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked What do the struck prices mean? Nothing published explains them. They imply a 55% cut on one line and 11% on the other. Why is tirzepatide so much dearer? The page does not say. The gap is $270 a month. What does six months cost? $774 for semaglutide or $2,394 for tirzepatide. Is Bioverse expensive compared with other GLP-1 telehealth sellers? Bioverse publishes a starting figure of $129/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Bioverse below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).